Position in VCEL
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$444
-$135 QoQ
Shares Held
10
-44.4% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#307
of 315 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in VCEL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Ankerstar Wealth, LLC holds $10,759 across 16 Biotechnology names. VCEL ranks #8 (4.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TGTX |
Tg Therapeutics, Inc.
|
30 | $1,648 | |
| 2 | KRYS |
Krystal Biotech, Inc.
|
4 | $1,486 | |
| 3 | PTGX |
Protagonist Therapeutics, Inc
|
12 | $1,470 | |
| 4 | CORT |
Corcept Therapeutics Inc
|
15 | $1,304 | |
| 5 | LGND |
Ligand Pharmaceuticals Inc
|
3 | $948 | |
| 6 | PTCT |
Ptc Therapeutics, Inc.
|
10 | $815 | |
| 7 | XNCR |
Xencor Inc
|
34 | $547 | |
| 8 | VCEL |
Vericel Corp
This page
|
10 | $444 |
All Filings in VCEL
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $444 | 10 | Shares | Other | 2026-08-13 | |
| 2026-03-31 | $579 | 18 | Shares | Other | 2026-05-14 | |
| 2025-12-31 | $288 | 8 | Shares | Other | 2026-02-12 | |
| No filing history on record for this holder in this stock. | ||||||